跳至主導覽
跳至搜尋
跳過主要內容
國立成功大學 首頁
English
中文
在 國立成功大學 搜尋內容
首頁
概要
研究單位
研究成果
專案
學生論文
設備
獎項
活動
查看斯高帕斯 (Scopus) 概要
凌 怡婷
副教授
公共衛生學科暨研究所
https://orcid.org/0000-0003-4415-2471
電話
886-6-2353535 ext.5870
電子郵件
z11208019
ncku.edu
tw
h-index
2276
引文
21
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
2008
2025
每年研究成果
概覽
指紋
網路
研究成果
(72)
類似的個人檔案
(2)
指紋
查看啟用 Daphne I. Ling 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Medicine and Dentistry
Patient-Reported Outcome
87%
Shoulder Arthroplasty
68%
Interferon Gamma Release Assay
68%
Mantoux Test
61%
Systematic Review
61%
Total Shoulder Arthroplasty
56%
Injury Prevention
51%
Meta-Analysis
47%
Athletes
40%
Reverse Shoulder Arthroplasty
39%
Comorbidity
37%
Anterior Cruciate Ligament Reconstruction
37%
Rotator Cuff
35%
Magnetic Resonance Imaging
34%
QuantiFERON
33%
Latent Tuberculosis
28%
Anterior Cruciate Ligament
26%
Minimal Clinically Important Difference
26%
Cost-Effectiveness Analysis
25%
American Shoulder and Elbow Surgeons Score
24%
Short Form 12
24%
Isoniazid
22%
Elixhauser Comorbidity Index
21%
Pediatrics
20%
Osteoarthritis
19%
Diseases
19%
Anterior Cruciate Ligament Injury
19%
Sensitivity and Specificity
19%
Diagnostic Accuracy
18%
Randomized Controlled Trial
18%
Release Assay
17%
Womens Health
17%
Restylane
17%
Childhood Tuberculosis
17%
Severe Acute Respiratory Syndrome
17%
Clinician
17%
Ulcer
17%
Nucleic Acid Amplification
17%
Tenodesis
17%
Multidrug Resistant Tuberculosis
17%
Infectious Disease
17%
Lipoarabinomannan
17%
Hip Arthroscopy
17%
Hip Arthroplasty
17%
Interferon
17%
Urea Breath Test
17%
Helicobacter Infection
17%
Plyometrics
17%
Cardiovascular System
17%
Ankle Injury
17%
Nursing and Health Professions
Athletes
100%
Systematic Review
89%
Injury Prevention
85%
Meta Analysis
67%
Anterior Cruciate Ligament Injury
56%
Rate Ratio
49%
Patient-Reported Outcome
40%
Shoulder Arthroplasty
34%
Anterior Cruciate Ligament Reconstruction
34%
Gender Difference
34%
Return To Sport
34%
Medline
19%
Reverse Shoulder Arthroplasty
17%
Medical Personnel
17%
Postconcussion Syndrome
17%
Patella Dislocation
17%
Nuclear Magnetic Resonance Imaging
17%
Nucleic Acid Amplification
17%
Effect Size
17%
South Africa
17%
Plyometrics
17%
Hip Arthroscopy
17%
Lung Tuberculosis
17%
Mump
17%
Diagnostic Accuracy
17%
Knee Arthroplasty
17%
Tenodesis
17%
Hyaluronic Acid
17%
American Shoulder and Elbow Surgeons Score
17%
Athletic Trainer
17%
Recall Bias
17%
Pilot Study
17%
Release Assay
17%
Knee Osteoarthritis
17%
Cochrane Library
15%
Tuberculin Test
15%
Female Athletes
13%
Viscosupplementation
12%
Musculoskeletal Pain
12%
Practice Guideline
11%
Leg Injury
10%
Ankle Fracture
10%
Recurrent Dislocation
9%
Pain Intensity
8%
Fisher Exact Test
8%
Cost Effectiveness Analysis
8%
Cohort Analysis
7%
Confidence Interval
7%
Recurrent Shoulder Dislocation
7%
Tertiary Care Center
7%
Keyphrases
Tuberculin Skin Test
34%
Tuberculosis
27%
Interferon-gamma Release Assay
25%
Meta-analysis
25%
Early Cost-effectiveness
17%
Cost-effectiveness Modeling
17%
Residency Applicants
17%
Orthopedic Surgery Residency
17%
Active Tuberculosis
17%
Single Assessment Numeric Evaluation
17%
Post-concussion Syndrome
17%
Semi-professional
17%
Nucleic Acid Amplification Test
17%
Women's Soccer
17%
Respiratory Infectious Diseases
17%
Public Research
17%
Female Soccer Players
17%
Cardiovascular Screening
17%
Olympic Athletes
17%
Core Decompression
17%
Running Performance
17%
Chief Medical Officer
17%
Rio 2016 Olympic Games
17%
Performing Artists
17%
On-field Performance
17%
Respiratory Infection
17%
TB Diagnosis
17%
Arthroscopic Shoulder Stabilization
17%
Revision Stabilization
17%
Lipoarabinomannan
17%
Blood Test
17%
Systematic Meta-analysis
17%
Predictive Value
17%
Evidence-based Analysis
17%
Outcome Value
17%
Pulmonary Tuberculosis
17%
Influenza
17%
Hip Arthroscopy
17%
Measles-mumps-rubella
17%
Respiratory Specimens
17%
Anterior Stabilization
17%
Athletic Population
17%
Biceps Transfer
17%
Tuberculosis in children
17%
Unicompartmental Knee Arthroplasty
17%
Patellofemoral Arthroplasty
17%
New Diagnostics
17%
ACL Injury Prevention
17%
Evidence-to-policy
17%
Risk Factors for Injury
17%
